Alza, Therapeutic Discovery Corp., Ferring Group deal

AZA exercised its option to license a non-scrotal transdermal testosterone product from TDCA for

Read the full 141 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE